|
|
中心动脉压关键指标与慢性肾脏病进展至透析的关系探讨
|
Abstract:
目的：探讨中心动脉压关键指标是否与慢性肾脏病进展至透析有关。方法：本研究为回顾性队列研究，选取2017年2月至2019年10月在浙江省人民医院肾脏病科接受无创中心动脉压测量，且符合研究纳入及排除标准的306例慢性肾脏病住院患者为研究对象，研究终点为接受透析治疗，随访时间截止至2022年2月。从电子病历系统中检索患者的一般信息、实验室指标、中心动脉血压各个参数，其中中心动脉收缩压(CSBP)和中心动脉脉压(CPP)作为关键指标。根据基线CSBP和CPP水平四分位数，分别将研究对象分为Q1，Q2，Q3和Q4组，分别绘制CSBP和CPP的Kaplan-Meier曲线，建立Cox比例风险回归模型以探索CSBP和CPP是否为慢性肾脏病进展至透析的独立危险因素。结果：共纳入306例患者，随访时间为1061 (911, 1458)天。截止至随访结束，共有50例进入透析。在CSBP分组中，Q1至Q4组进展至透析的发生率依次为5.5%、13.6%、16.7%、29.7%；在CPP分组中，Q1至Q4组进展至透析的发生率分别为3.7%、17.1%、14.3%、33.8%，组间比较差异有统计学意义(p < 0.001)。Cox回归分析结果显示，与低水平的Q1组相比，CSBP高水平Q4组进入透析的风险比(HR)在模型1 (未校正模型)、模型2和模型3中分别为6.65 (2.29~19.35)，5.46 (1.83~16.26)，3.30 (1.01~10.75)。Kaplan-Meier曲线分析显示，CSBP四组间的肾脏累积生存率差异有统计学意义(p < 0.001)。类似的，与低水平的Q1组相比，CPP高水平Q4组在进入透析的风险比(HR)在模型1 (未校正模型)、模型2和模型3中分别为11.22 (3.35~37.62)，10.47 (2.91~37.67)，3.75 (1.07~13.12)。Kaplan-Meier曲线分析显示，CPP四组间的肾脏累积生存率差异有统计学意义(p < 0.001)。结论：高水平的中心动脉收缩压(CSBP)和中心动脉脉压(CPP)与慢性肾脏病进展至透析风险增加独立相关，可能是早期识别慢性肾脏病进展至透析的无创标记物。
Objective: To investigate whether the key index of central arterial pressure is related to the progression of chronic kidney disease to dialysis. Methods: This study was a retrospective cohort study. 306 inpatients with chronic kidney disease who received noninvasive central arterial pressure measurement at the Department of Nephrology, Zhejiang Provincial People’s Hospital from February 2017 to October 2019 and met the inclusion and exclusion criteria were selected as the study subjects. The study endpoint was dialysis treatment, and the follow-up period ended in February 2022. The general information, laboratory indicators and central arterial blood pressure parameters were retrieved from the electronic medical record system, among which the central arterial systolic blood pressure (CSBP) and central arterial blood pressure (CPP) were the key indicators. According to the baseline quartile of CSBP and CPP levels, the subjects were divided into Q1, Q2, Q3 and Q4 groups, respectively. Kaplan-Meier curves of CSBP and CPP were plotted respectively, and Cox proportional risk regression model was established to explore whether CSBP and CPP were independent risk factors for progression to dialysis. Results: A total of 306 patients were included and followed up for 1061 (911, 1458) days. Up to the end of follow-up, a total of 50 patients entered dialysis. In the CSBP group, the incidence of progression to dialysis in groups Q1 to Q4 was 5.5%, 13.6%, 16.7% and 29.7%, respectively. In the CPP group, the incidence of progression to dialysis in groups Q1 to Q4 was 3.7%, 17.1%, 14.3% and 33.8%, respectively, with
| [1] | Foreman, K.J., Marquez, N., Dolgert, A., Fukutaki, K., Fullman, N., McGaughey, M., et al. (2018) Forecasting Life Expectancy, Years of Life Lost, and All-Cause and Cause-Specific Mortality for 250 Causes of Death: Reference and Alternative Scenarios for 2016-40 for 195 Countries and Territories. The Lancet, 392, 2052-2090. https://doi.org/10.1016/s0140-6736(18)31694-5 |
| [2] | Bikbov, B., Purcell, C.A., Levey, A.S., Smith, M., Abdoli, A., Abebe, M., et al. (2020) Global, Regional, and National Burden of Chronic Kidney Disease, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 395, 709-733. https://doi.org/10.1016/s0140-6736(20)30045-3 |
| [3] | Wang, L., Xu, X., Zhang, M., Hu, C., Zhang, X., Li, C., et al. (2023) Prevalence of Chronic Kidney Disease in China. JAMA Internal Medicine, 183, 298-310. https://doi.org/10.1001/jamainternmed.2022.6817 |
| [4] | Lv, J.-C. and Zhang, L.-X. (2019) Prevalence and Disease Burden of Chronic Kidney Disease. Advances in Experimental Medicine and Biology, 1165, 3-15. |
| [5] | Zhang, L., Wang, F., Wang, L., Wang, W., Liu, B., Liu, J., et al. (2012) Prevalence of Chronic Kidney Disease in China: A Cross-Sectional Survey. The Lancet, 379, 815-822. https://doi.org/10.1016/s0140-6736(12)60033-6 |
| [6] | Pugh, D., Gallacher, P.J. and Dhaun, N. (2019) Management of Hypertension in Chronic Kidney Disease. Drugs, 79, 365-379. https://doi.org/10.1007/s40265-019-1064-1 |
| [7] | Whelton, P.K., Carey, R.M., Aronow, W.S., Casey Jr., D.E., Collins, K.J., Dennison Himmelfarb, C., et al. (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, e13-e115. |
| [8] | McEniery, C.M., Cockcroft, J.R., Roman, M.J., Franklin, S.S. and Wilkinson, I.B. (2014) Central Blood Pressure: Current Evidence and Clinical Importance. European Heart Journal, 35, 1719-1725. https://doi.org/10.1093/eurheartj/eht565 |
| [9] | Karamanoglu, M., O’rourke, M.F., Avolio, A.P. and Kelly, R.P. (1993) An Analysis of the Relationship between Central Aortic and Peripheral Upper Limb Pressure Waves in Man. European Heart Journal, 14, 160-167. https://doi.org/10.1093/eurheartj/14.2.160 |
| [10] | Ohno, Y. (2016) Central Blood Pressure and Chronic Kidney Disease. World Journal of Nephrology, 5, 90-100. https://doi.org/10.5527/wjn.v5.i1.90 |
| [11] | Cheung, A.K., Chang, T.I., Cushman, W.C., Furth, S.L., Hou, F.F., Ix, J.H., et al. (2021) KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney International, 99, S1-S87. https://doi.org/10.1016/j.kint.2020.11.003 |
| [12] | Roman, M.J. and Devereux, R.B. (2014) Association of Central and Peripheral Blood Pressures with Intermediate Cardiovascular Phenotypes. Hypertension, 63, 1148-1153. https://doi.org/10.1161/hypertensionaha.114.03361 |
| [13] | Roman, M.J., Devereux, R.B., Kizer, J.R., Lee, E.T., Galloway, J.M., Ali, T., et al. (2007) Central Pressure More Strongly Relates to Vascular Disease and Outcome than Does Brachial Pressure. Hypertension, 50, 197-203. https://doi.org/10.1161/hypertensionaha.107.089078 |
| [14] | Chirinos, J.A., Zambrano, J.P., Chakko, S., Veerani, A., Schob, A., Willens, H.J., et al. (2005) Aortic Pressure Augmentation Predicts Adverse Cardiovascular Events in Patients with Established Coronary Artery Disease. Hypertension, 45, 980-985. https://doi.org/10.1161/01.hyp.0000165025.16381.44 |
| [15] | Wang, K., Cheng, H., Chuang, S., Spurgeon, H.A., Ting, C., Lakatta, E.G., et al. (2009) Central or Peripheral Systolic or Pulse Pressure: Which Best Relates to Target Organs and Future Mortality? Journal of Hypertension, 27, 461-467. https://doi.org/10.1097/hjh.0b013e3283220ea4 |
| [16] | Vlachopoulos, C., Aznaouridis, K., O’Rourke, M.F., Safar, M.E., Baou, K. and Stefanadis, C. (2010) Prediction of Cardiovascular Events and All-Cause Mortality with Central Haemodynamics: A Systematic Review and Meta-Analysis. European Heart Journal, 31, 1865-1871. https://doi.org/10.1093/eurheartj/ehq024 |
| [17] | Safar, M.E., Blacher, J., Pannier, B., Guerin, A.P., Marchais, S.J., Guyonvarc’h, P., et al. (2002) Central Pulse Pressure and Mortality in End-Stage Renal Disease. Hypertension, 39, 735-738. https://doi.org/10.1161/hy0202.098325 |
| [18] | Cohen, D.L. and Townsend, R.R. (2011) Central Blood Pressure and Chronic Kidney Disease Progression. International Journal of Nephrology, 2011, Article 407801. https://doi.org/10.4061/2011/407801 |
| [19] | Briet, M., Collin, C., Karras, A., Laurent, S., Bozec, E., Jacquot, C., et al. (2011) Arterial Remodeling Associates with CKD Progression. Journal of the American Society of Nephrology, 22, 967-974. https://doi.org/10.1681/asn.2010080863 |
| [20] | The CAFE Investigators, Williams, B., Lacy, P.S., Thom, S.M., Cruickshank, K., Stanton, A., et al. (2006) Differential Impact of Blood Pressure-Lowering Drugs on Central Aortic Pressure and Clinical Outcomes. Circulation, 113, 1213-1225. https://doi.org/10.1161/circulationaha.105.595496 |
| [21] | Fu, S., Guo, Y., Luo, L. and Ye, P. (2018) Association of Arterial Stiffness and Central Hemodynamics with Moderately Reduced Glomerular Filtration Rate in Chinese Middle-Aged and Elderly Community Residents: A Cross-Sectional Analysis. BMC Nephrology, 19, Article No. 103. https://doi.org/10.1186/s12882-018-0897-2 |
| [22] | Townsend, R.R. and Tomiyama, H. (2013) Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression. Pulse, 1, 123-130. https://doi.org/10.1159/000354113 |
| [23] | Fan, F., Qi, L., Jia, J., Xu, X., Liu, Y., Yang, Y., et al. (2016) Noninvasive Central Systolic Blood Pressure Is More Strongly Related to Kidney Function Decline than Peripheral Systolic Blood Pressure in a Chinese Community-Based Population. Hypertension, 67, 1166-1172. https://doi.org/10.1161/hypertensionaha.115.07019 |
| [24] | Roman, M.J., Devereux, R.B., Kizer, J.R., Okin, P.M., Lee, E.T., Wang, W., et al. (2009) High Central Pulse Pressure Is Independently Associated with Adverse Cardiovascular Outcome. Journal of the American College of Cardiology, 54, 1730-1734. https://doi.org/10.1016/j.jacc.2009.05.070 |
| [25] | Kim, J.Y., Bushnell, C.D., Park, J.H., Han, S.M., Im, J.H., Han, S.W., et al. (2014) Central Aortic Pressure and Pulsatility Index in Acute Ischemic Stroke. Journal of Neuroimaging, 25, 438-442. https://doi.org/10.1111/jon.12151 |
| [26] | Morgan, T. (2004) Effect of Different Antihypertensive Drug Classes on Central Aortic Pressure. American Journal of Hypertension, 17, 118-123. https://doi.org/10.1016/j.amjhyper.2003.09.012 |
| [27] | Chai, R., Li, S.-M., Xu, L.-S., Yao, Y. and Hao, L.-L. (2017) Regression Analysis and Transfer Function in Estimating the Parameters of Central Pulse Waves from Brachial Pulse Wave. 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Jeju, 11-15 July 2017, 1708-1711. https://doi.org/10.1109/embc.2017.8037171 |
| [28] | Gotzmann, M., Hogeweg, M., Seibert, F.S., Rohn, B.J., Bergbauer, M., Babel, N., et al. (2020) Accuracy of Fully Automated Oscillometric Central Aortic Blood Pressure Measurement Techniques. Journal of Hypertension, 38, 235-242. https://doi.org/10.1097/hjh.0000000000002237 |
| [29] | Ott, C., Haetinger, S., Schneider, M.P., Pauschinger, M. and Schmieder, R.E. (2012) Comparison of Two Noninvasive Devices for Measurement of Central Systolic Blood Pressure with Invasive Measurement during Cardiac Catheterization. The Journal of Clinical Hypertension, 14, 575-579. https://doi.org/10.1111/j.1751-7176.2012.00682.x |
